SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-12-004297
Filing Date
2012-04-16
Accepted
2012-04-16 06:01:04
Documents
6
Period of Report
2012-05-15
Effectiveness Date
2012-04-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2208847zdef14a.htm DEF 14A 1097664
2 G14702BAI001.GIF g14702bai001.gif GRAPHIC 85539
3 G14702BAI002.GIF g14702bai002.gif GRAPHIC 70824
4 G817752.JPG g817752.jpg GRAPHIC 6750
5 G979546.JPG g979546.jpg GRAPHIC 3974
6 G352051.JPG g352051.jpg GRAPHIC 6598
  Complete submission text file 0001047469-12-004297.txt   1338804
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 12759801
SIC: 2834 Pharmaceutical Preparations